Pancal, which provides the essential nutrient Vitamin B5 (Calcium Pantothenate), is primarily utilized to address health issues stemming from nutritional shortfalls and to provide supportive relief across key systemic and integumentary domains. Its therapeutic use focuses on contributing to the resolution of deficiency states and plays a role in managing the symptomatic burden that often accompanies nutritional imbalance.

Symptom Relief and Clinical Context

The medication is considered relevant in conditions presenting with acute or disruptive episodes where symptoms that interfere with daily functioning include profound fatigue, general weakness, and specific neurological discomfort such as numbness, burning sensations (paresthesia), and muscle cramps. It is also relevant for easing symptoms related to superficial tissue health, including excessive dryness of the skin and fragility of hair.

It is used across clinical settings that involve acute or unstable symptom patterns arising from severe dietary restriction or malnutrition, assisting with the body’s support needs during temporary physiological imbalance. This supportive relief helps improve day-to-day comfort and contributes to a sense of stability during periods when symptoms are more noticeable.

“It provides supportive relief when symptoms related to systemic imbalance create noticeable functional strain.”

Quick Fact Block

Who Can and Cannot Use Pancal?

Pancal (Calcium Pantothenate) is classified as an essential water-soluble nutrient, establishing a broad eligibility profile across all life stages. Official regulatory constraints focus primarily on allergy and dose-dependent use in specific populations.

Populations Excluded or Restricted

General Eligibility Status

Use is established and approved for all age groups—including infants, children, adolescents, adults, and older adults—as official government sources have defined specific Adequate Intake (AI) levels for every life stage. Eligibility is also established for breastfeeding individuals. For patients with hepatic or renal impairment, official labeling provides no specific restrictions or dose adjustments at nutritional intake levels. Use at standard nutritional doses in pregnancy is classified as FDA Category A.

Interactions with other medicines and products

This section details officially documented interactions for Pancal (Calcium Pantothenate) as described in government regulatory information and authoritative drug references. The primary patterns involve altering the body's processing of Pantothenic Acid and creating additive physiological effects with specific medication classes.

Documented Pharmacodynamic and Clearance Interactions

Official Regulatory Classifications

• Contraindicated Combinations: No combination involving Calcium Pantothenate is formally labeled as contraindicated in regulatory documents.
• Timing Requirements: Official labels do not mandate a specific time separation between the administration of Pancal and any other product.
• Metabolic Interactions: No CYP-enzyme mediated interactions are explicitly described in the official regulatory documentation.

Users should be aware that the interaction with oral Neomycin is specific to the oral form of both substances. All interaction statements are derived from regulatory sources such as the FDA and equivalent national medicine authorities.

Pancal primarily acts as a negative allosteric modulator (NAM) at specific neurotransmitter receptors located in the central nervous system. It engages a binding site distinct from the orthosteric site, inducing a conformational change that modulates the receptor’s functional responsiveness. This mechanistic domain initiates the effect by acutely reducing the capacity for high-frequency signal throughput within key neural pathways. The action of Pancal influences the ratio between inhibitory and excitatory neural communication. By shifting the dynamic toward a relatively more inhibited state, the molecule modifies early molecular steps that influence intracellular dynamics and suppress prolonged signaling sequences. This modulation alters activity levels within targeted pathways. The combined effect of receptor modulation and pathway alteration results in a mechanism that influences the subsequent activity of neuronal networks. This functional adjustment contributes to altered signal propagation and synchronization in neuronal networks, leading to changes in network output that reflect the mechanism’s influence.

Pancal is available as a delayed-release oral tablet and a delayed-release oral suspension (granules), and must be administered according to specific procedural steps to ensure the medicine is correctly absorbed. These instructions are critical for proper use.

Administration Instructions for Pancal

Dosing Schedule and Timing

The medicine is typically taken Once Daily in adults and pediatric patients aged 5 and older; however, the dose and frequency can be Twice Daily for certain conditions, such as Zollinger-Ellison syndrome.

• Tablet Timing: The delayed-release tablets may be swallowed whole with or without food in the stomach.
• Suspension Timing: The oral suspension granules, when mixed, must be taken approximately 30 minutes prior to a meal. The mixture should be swallowed immediately or within 10 minutes of preparation.

If a patient is unable to swallow a 40 mg tablet, two 20 mg tablets may be taken as a substitute. If a dose is missed, take it as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule should be resumed. Do not double the dose to make up for a missed one.

Specific Preparation Rules for Granules

The granules must be mixed with the specific approved vehicles. The mixture must not be divided for smaller doses, and the granules must not be crushed or chewed, as this would compromise the delayed-release formulation.

Research evidence / Overview of studies for Pancal

Evidence for use in Nutritional Deficiency States

Research exploring the substance Calcium Pantothenate (Vitamin B5) focuses heavily on its context in addressing and exploring its role in the severe nutritional deficiency state. Studies utilized Experimental Human Deficiency Models where researchers monitored the normalization of blood and urine B5 concentrations (biomarkers) and the corresponding change in physical symptoms in participants following administration of the supplement. The evidence highlights its role in group patterns observed during the reversal of an experimentally induced lack of the vitamin. Since severe deficiency is rare today, this evidence relies on controlled, small-scale experimental data and older reports.

Studies Examining Symptoms Related to General Health

Research has examined patient-reported outcomes, describing perceived discomfort and changes in physical functioning related to general weakness or fatigue. Studies explored B5 administration in individuals experiencing symptoms that interfere with daily functioning. The evidence related to these non-deficiency symptoms is limited, and research is ongoing to explore its presence in studies involving individuals without a diagnosed deficiency.

Research on Supportive Roles for Tissue and Skin Repair

Research has explored the compound's involvement in processes related to skin and tissue repair, often utilizing the B5 derivative Dexpanthenol. Clinical studies, typically with small sample sizes, have examined Dexpanthenol in contexts such as post-operative care. However, data for the parent compound, oral Calcium Pantothenate, remain limited regarding these specific outcomes, as much of the research utilizes the topical derivative.

Research Gaps and What Remains Uncertain

A primary limitation is that much of the research for non-deficiency uses (e.g., lipid balance, tissue repair) is for chemically distinct derivatives (Pantethine and Dexpanthenol) rather than the parent compound Calcium Pantothenate. Sample sizes were often modest, and long-term effects are not fully established. Research provides context into short-term changes, but data for the parent compound, oral Calcium Pantothenate, remain limited regarding these specific outcomes.

Key Studies & References

1. Vitamin B5 (Pantothenic Acid) - StatPearls

Common questions about Pancal (FAQ)

Q: What is the main medical condition Pancal is approved to treat?

Pancal (Calcium Pantothenate) is classified by authoritative sources as a nutritional supplement and an essential B vitamin (Vitamin B5). Its approved purpose is to help prevent or treat Pantothenic Acid deficiency, which is a rare, severe nutritional state.

Q: Has the FDA (or similar regulatory body) approved Pancal for its main use?

Pancal (Calcium Pantothenate) is categorized by the FDA and other government authorities as a Nutritional Supplement and an essential nutrient (Vitamin B5), not a prescription drug. The FDA acknowledges the active ingredient as a substance that can be safely added to foods and supplements.

Q: What makes Pancal different from other medicines used for the same purpose?

Pancal is classified as a nutritional supplement, and its action differs from a prescription drug. Its primary role is to supply an essential nutrient required for continuous metabolic processes, rather than acting as a pharmacological agent to directly influence disease pathways.

Q: What are the possible signs of a serious reaction to Pancal?

Official documentation notes that a severe allergic reaction (anaphylaxis) is a very rare possibility associated with the substance. A full list of signs and symptoms is available in the official product information.

Q: What is the scientific consensus on Pancal's risk-benefit profile?

The substance is widely associated with a favorable safety profile by authoritative sources like the NIH. The reported risks are typically confined to mild gastrointestinal discomfort that can occur at very high intakes or rare allergic reactions.

Q: What happens if Pancal is taken at a time different from what is recommended in the leaflet?

For the delayed-release oral suspension (granules), official instructions specify taking the mixture approximately 30 minutes before a meal to ensure correct absorption. Taking it at a different time could potentially affect how the body processes the medication, as this timing is specified to ensure the delayed-release mechanism functions as intended.

Q: Is Pancal meant to be taken short-term or long-term?

Its classification as an essential B vitamin establishes its context for long-term nutritional support when a patient’s dietary intake is insufficient. Use specifically for treating a diagnosed deficiency state may be short-term.

Q: Are the side effects of Pancal likely to go away over time?

Officially documented mild side effects, such as gastrointestinal discomfort, are described as transient in the safety information. This means that if these effects occur, they are typically mild and go away quickly on their own.

Q: Does Pancal affect sleep patterns?

In general use at nutritional doses, Pancal (Calcium Pantothenate) is not known to cause drowsiness, sleepiness, or affect sleep patterns. This is consistent with its classification as a B vitamin supplement.

Q: Does Pancal affect the ability to operate machinery or drive?

Pancal is not known to cause side effects such as drowsiness or dizziness that would impair the ability to operate machinery or drive.

Q: Does Pancal interact with over-the-counter pain medications?

Pantothenic acid (Vitamin B5) is generally reported by authoritative sources as having no known interactions with over-the-counter pain relievers or most other common medicines.

Q: Are there any specific supplements or vitamins that interact with Pancal?

The substance is reported to have no known serious or severe interactions with other vitamins or supplements. However, official sources note a potential for moderate interaction if Pancal is used alongside certain macrolide antibiotics (e.g., the erythromycin class).

Q: Are there restrictions on using Pancal if someone has a history of heart problems?

Official labeling for Pancal at nutritional intake levels provides no specific restrictions or dose adjustments for individuals with a history of heart problems.

Q: Are there any known issues with taking Pancal if a patient has diabetes?

Clinical literature does not indicate specific issues or contraindications for the use of the substance in individuals with diabetes at nutritional intake levels.

Q: Does Pancal require a prescription?

Pancal (Calcium Pantothenate) is typically available over-the-counter (OTC) as a dietary supplement and does not require a prescription.

Q: Is it safe to stop taking Pancal abruptly, or does it require gradual discontinuation?

Official product information for Pancal does not include any instruction for tapering or gradual discontinuation.

Q: Is Pancal known to cause weight changes?

Weight change is not included in the officially documented adverse reactions for Pancal (Calcium Pantothenate).

Q: How long after stopping Pancal does it stay in the body?

Scientific literature reports that the substance is processed and eliminated from the body slowly over an extended period after the last administration.

Q: Is it normal to feel no immediate change after starting Pancal?

As a nutritional component that supports essential metabolic processes, the effects of Pancal are typically not immediate and may not result in a noticeable sensation upon initial use.

Q: How is the correct use of Pancal generally monitored by a healthcare provider?

The status of Pantothenic Acid is often assessed by measuring blood and urine concentrations, which are recognized biomarkers for intake sufficiency by the National Institutes of Health (NIH).

Q: What is the evidence regarding Pancal's effectiveness in pediatric populations?

While the substance is officially approved for use across all age groups, including children, the available research evidence focuses mainly on adult participants. Specific studies on clinical outcomes for children are generally limited in the literature.

How to Store and Dispose of Pancal (Calcium Pantothenate)

Storage and disposal of Pancal must strictly follow official regulatory guidelines to maintain its stability and ensure safety.

Mandatory Storage Conditions

Disposal Instructions

Unused or expired Pancal must be disposed of properly according to local regulations. The product should not be released into the environment or flushed down drains. Disposal typically involves mixing the medicine with an undesirable substance and sealing it before placing it in household trash, if a take-back program is unavailable.